Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
4(29%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
11
79%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(7)
Other(2)

Detailed Status

Completed7
Recruiting3
unknown2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (8.3%)
N/A11 (91.7%)

Trials by Status

not_yet_recruiting17%
unknown214%
active_not_recruiting17%
recruiting321%
completed750%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14